08:35 AM EDT, 07/16/2025 (MT Newswires) -- Tempus AI ( TEM ) said Wednesday that its ECG-Low ejection fraction software has received 510(k) clearance from the US Food and Drug Administration.
The company said the software is designed to help identify patients who may have a low left ventricular ejection fraction.
Shares of Tempus AI ( TEM ) were up 4% in recent Wednesday premarket activity.